{"disease":{"id":"agitation","name":"agitation"},"drugs":{"marketed":[{"drug_id":"aripiprazole","indication_name":"Agitation associated with Bipolar Mania","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abilify","generic_name":"aripiprazole","company_name":"Generic (originally Otsuka/BMS)","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 6","drug_class":"Third-generation antipsychotic (D2 partial agonist)","quality_score":63,"revenue":"3000","mechanism":"Third-generation antipsychotic that acts as a partial agonist at D2 and 5-HT1A receptors, stabilizing dopamine activity rather than simply blocking it."},{"drug_id":"aripiprazole","indication_name":"Agitation associated with Schizophrenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abilify","generic_name":"aripiprazole","company_name":"Generic (originally Otsuka/BMS)","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 6","drug_class":"Third-generation antipsychotic (D2 partial agonist)","quality_score":63,"revenue":"3000","mechanism":"Third-generation antipsychotic that acts as a partial agonist at D2 and 5-HT1A receptors, stabilizing dopamine activity rather than simply blocking it."},{"drug_id":"olanzapine","indication_name":"Agitation associated with Schizophrenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zyprexa","generic_name":"olanzapine","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"Atypical Antipsychotic [EPC]","quality_score":10,"revenue":"300","mechanism":null},{"drug_id":"olanzapine","indication_name":"Agitation associated with Bipolar Mania","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zyprexa","generic_name":"olanzapine","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"Atypical Antipsychotic [EPC]","quality_score":10,"revenue":"300","mechanism":null},{"drug_id":"abilify","indication_name":"Agitation associated with Bipolar Mania","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Abilify","company_name":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 6","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"zyprexa","indication_name":"Agitation associated with Schizophrenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zyprexa","company_name":"Washington University School of Medicine","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"abilify","indication_name":"Agitation associated with Schizophrenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Abilify","company_name":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 6","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ziprasidone","indication_name":"Agitation associated with Schizophrenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Geodon","generic_name":"ziprasidone","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Aspartate aminotransferase, cytoplasmic, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"Atypical antipsychotic (second-generation)","quality_score":10,"revenue":null,"mechanism":"Atypical antipsychotic that antagonizes dopamine D2 and serotonin 5-HT2A receptors with the least metabolic side effects in its class."},{"drug_id":"zyprexa","indication_name":"Agitation associated with Bipolar Mania","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zyprexa","company_name":"Washington University School of Medicine","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06556069","title":"Clinical Trial of Peer Support in the ED (PCORI)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":57870,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT05765162","title":"Safe Brain Initiative, Operationalizing Precision Anaesthesia","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT04957238","title":"Physical Restraints in Intensive Care Unit Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT03773874","title":"Assessment of Analgesia, Sedation, Physical Restraints and Delirium in Spanish Intensive Care Units","phase":"","overall_status":"COMPLETED","enrollment_count":1574,"lead_sponsor_name":"Hospital Universitario Getafe","has_results":false},{"nct_id":"NCT05624424","title":"Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":1317,"lead_sponsor_name":"Second Affiliated Hospital of Nanchang University","has_results":false},{"nct_id":"NCT02446132","title":"Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1197,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT03211897","title":"Olanzapine, Haloperidol, Ziprasidone, Midazolam for Acute Undifferentiated Agitation","phase":"","overall_status":"COMPLETED","enrollment_count":737,"lead_sponsor_name":"Hennepin Healthcare Research Institute","has_results":false},{"nct_id":"NCT03398759","title":"Butorphanol Mitigate Emergence Agitation in Patients Undergoing Functional Endoscopic Sinus Surgery","phase":"NA","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT06896721","title":"Effects of Nasal Administration of Dexmedetomidine on Pre-anesthesia Sedation, Intraoperative Brain Electrical Activity, and Incidence of Agitation During Recovery in Children","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":627,"lead_sponsor_name":"Fuzhou Hua","has_results":false},{"nct_id":"NCT03393520","title":"Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":601,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":false},{"nct_id":"NCT06937229","title":"A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT02442778","title":"Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":522,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT04270331","title":"Assessment and Management of Pain, Agitation, Delirium and Sleep Deprivation (PADS) in ICU by PADS Protocol, Thailand","phase":"NA","overall_status":"COMPLETED","enrollment_count":509,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT03216941","title":"Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Universidad Nacional de Rosario","has_results":false},{"nct_id":"NCT07253428","title":"Emergence Agitation","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":486,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT05783505","title":"A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use","phase":"NA","overall_status":"RECRUITING","enrollment_count":480,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04947553","title":"A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":456,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05658510","title":"Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":452,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":false},{"nct_id":"NCT01862640","title":"A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":433,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT03620981","title":"Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":410,"lead_sponsor_name":"Otsuka Pharmaceutical Co., Ltd.","has_results":true},{"nct_id":"NCT05557409","title":"A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":408,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT02442765","title":"Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":387,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT04268303","title":"Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":380,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":true},{"nct_id":"NCT04276883","title":"Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":380,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":true},{"nct_id":"NCT03226522","title":"Addressing Dementia Via Agitation-Centered Evaluation","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":366,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":true},{"nct_id":"NCT05769530","title":"Advanced Analgesia on the Quality of Recovery After General Anesthesia in Elderly Patients","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":360,"lead_sponsor_name":"Lili Jia","has_results":false},{"nct_id":"NCT04829500","title":"Effectiveness and Implementation of Montessori Approaches in Person-Centered Care Within VA","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":356,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT05451381","title":"Vasopressor Requirements Depends on Sedation Strategy","phase":"NA","overall_status":"COMPLETED","enrollment_count":356,"lead_sponsor_name":"Anesthesia Research Group UA","has_results":false},{"nct_id":"NCT06648122","title":"Association of Inflammatory Markers With Preoperative Anxiety and Agitation","phase":"","overall_status":"COMPLETED","enrollment_count":350,"lead_sponsor_name":"Cukurova University","has_results":false},{"nct_id":"NCT03548584","title":"A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":345,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT02525991","title":"Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":323,"lead_sponsor_name":"Ferrer Internacional S.A.","has_results":false},{"nct_id":"NCT04266340","title":"Different Premedication in Pediatric Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"Eye & ENT Hospital of Fudan University","has_results":false},{"nct_id":"NCT05803642","title":"A Study of Olanzapine in Patients With Acute Agitation","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":318,"lead_sponsor_name":"Qilu Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03554915","title":"Ketamine Versus Midazolam for Prehospital Agitation","phase":"","overall_status":"COMPLETED","enrollment_count":314,"lead_sponsor_name":"Hennepin Healthcare Research Institute","has_results":false},{"nct_id":"NCT06686511","title":"The Effect of Preoperative Counseling on Emergence Agitation in Patients Candidate for Nasal Surgeries","phase":"","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT04464564","title":"Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":241,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT06495957","title":"Electroacupuncture for the Treatment of Agitated Symptoms of Alzheimer's Disease","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":224,"lead_sponsor_name":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","has_results":false},{"nct_id":"NCT01584440","title":"Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Avanir Pharmaceuticals","has_results":true},{"nct_id":"NCT03899506","title":"Olanzapine Versus Midazolam for Agitation","phase":"","overall_status":"TERMINATED","enrollment_count":206,"lead_sponsor_name":"Hennepin Healthcare Research Institute","has_results":false},{"nct_id":"NCT07265050","title":"Comparison of Emergence Agitation Between Remimazolam With Flumazenil and Propofol-based Total Intravenous Anesthesia in Patients Undergoing Nasal Surgery","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":204,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT04844333","title":"Effect of Extubation Under Deep Anesthesia on Emergence Agitation of Nasal Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University","has_results":false},{"nct_id":"NCT04820595","title":"Postoperative Neurocognitive Dysfunction: Is There Any Place for Emergency Agitation: A Prospective Cohort Trial","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Negovsky Reanimatology Research Institute","has_results":false},{"nct_id":"NCT04765488","title":"WashIn /WashOut Procedure To Prevent Agitation During Recovery After Inhalational Anesthesia With Sevoflurane","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":false},{"nct_id":"NCT05330494","title":"Effects of Perioperative TEAS on Postoperative Pain and Agitation in Pediatric Adenoidectomy and Tonsillectomy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Xian Children's Hospital","has_results":false},{"nct_id":"NCT05313659","title":"Intramuscular Ketamine Effect on Postnasal Surgery Agitation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":193,"lead_sponsor_name":"Jordanian Royal Medical Services","has_results":false},{"nct_id":"NCT04408755","title":"Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":184,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT04797715","title":"Assessing Clinical Outcomes in Alzheimer's Disease Agitation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT02817906","title":"ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":177,"lead_sponsor_name":"Intra-Cellular Therapies, Inc.","has_results":true},{"nct_id":"NCT04514432","title":"Mindful Melody: Feasibility of Implementing Music Listening on an Inpatient Psychiatric Unit and Its Relation to the Use of As Needed Medications for Acute Agitation","phase":"","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"State University of New York - Upstate Medical University","has_results":false},{"nct_id":"NCT04908605","title":"Emergence Agitation After Nasal Surgery: a Randomized Controlled Comparison Between Melatonin and Mirtazapine","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":165,"lead_sponsor_name":"Ain Shams University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}